این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Medical Sciences، جلد ۵۰، شماره ۳، صفحات ۱۷۹-۱۸۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Epidemiology of Burden of Prostate Cancer in Iran during 2009-2019: Estimates from the Global Burden of Disease Study 2019
چکیده انگلیسی مقاله Background: Prostate cancer (PC) is the second most common cancer in men and the fifth leading cause of death worldwide. The purpose of this study is to investigate the epidemiological situation concerning the incidence, prevalence, and burden of prostate cancer in Iran from 2009 to 2019.
Methods: The present research is a descriptive-analytical study. To assess the spatial distribution of prostate cancer, data on the incidence, mortality, Disability-adjusted life years (DALY), Years of Life Lost due to premature mortality (YLL), and Years of Life Lost due to disability (YLD) in each province of Iran from 2009 to 2019 were obtained from the Global Burden of Disease (GBD) 2019 website. The incidence and mortality zoning in Iran was mapped using the ArcGIS 10.3 environment. The two-variable Pearson correlation coefficient was used to analyze the data extracted to study the correlation between PC and the Human Development Index.
Results: The highest Age-Standardized Incidence Rate (ASIR) of prostate cancer (40.55 per 100,000), mortality (17.09 per 100,000), YLL (254.1 per 100,000), YLD (23.88 per 100,000), and DALY (277.98 per 100,000) is related to Bushehr province. The results of the Pearson correlation reveal a positive and statistically significant correlation between the ASIR of prostate cancer and the Human Development Index (r=0.651, P=0.0001) in Iran. The highest Percentage of Annual Changes (PAC) in ASIR, Age-Standardized Mortality Rate (ASMR), Age-Standardized Prevalence Rate (ASPR), YLL, YLD, and DALY were related to the provinces of West Azarbayejan (62.9%), Golestan (30.86%), West Azarbayejan (87.66%), Golestan (29.38%), West Azarbayejan (76.95%), and Alborz (31.45%), respectively.
Conclusion: The incidence and mortality rates of prostate cancer in all provinces of the country are on the rise. Therefore, screening programs for early detection to reduce the mortality of the disease, and etiology studies to identify the causes of increased incidence and related factors, can be effective in controlling this cancer in the country.
کلیدواژه‌های انگلیسی مقاله Morbidity,Mortality,Disability-adjusted life years,Prostate neoplasms,Iran
نویسندگان مقاله Elham Goodarzi |
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khoram abad, Iran

Saeed Rajaei Ramesh |
Cilinical Research Development Unit, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran

Sajjad Rahimi Pordanjani |
Department of Public Health, Behbahan Faculty of Medical Sciences, Behbahan, Iran

Mahshid Abbasi |
Department of Radiation Oncology, School of Medicine, Lorestan University of Medical Sciences, Khoram abad, Iran

Fazlollah Fathollahi Shoorabeh |
Nutrition Health Research Center, School of Medicine, Lorestan University of Medical Sciences, Khoram abad, Iran

نشانی اینترنتی https://ijms.sums.ac.ir/article_50405_9ec82837670b9bab4db38d5290d40550.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات